A new retrospective study indicates that while GLP-1 receptor agonists for diabetes may slightly increase the risk of new-onset diabetic retinopathy, they also significantly reduce the risk of vision loss. Experts emphasize the importance of regular eye examinations for patients.
Recent studies suggest a link between GLP-1 medications like Ozempic and vision loss. Learn about the risks and what you need to know if you're using these popular diabetes drugs.
